Article

Engineering fibrotic tissue in pancreatic cancer: A novel three-dimensional model to investigate nanoparticle delivery

Department of Molecular Pathology, Graduate School of Medicine, University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-0033, Japan.
Biochemical and Biophysical Research Communications (Impact Factor: 2.28). 03/2012; 419(1):32-7. DOI: 10.1016/j.bbrc.2012.01.117
Source: PubMed

ABSTRACT Pancreatic cancer contains both fibrotic tissue and tumor cells with embedded vasculature. Therefore anti-cancer nanoparticles need to extravasate from tumor vasculature and permeate thick fibrotic tissue to target tumor cells. To date, permeation of drugs has been investigated in vitro using monolayer models. Since three-dimensional migration of nanoparticles cannot be analyzed in a monolayer model, we established a novel, three-dimensional, multilayered, in vitro model of tumor fibrotic tissue, using our hierarchical cell manipulation technique with K643f fibroblasts derived from a murine pancreatic tumor model. NIH3T3 normal fibroblasts were used in comparison. We analyzed the size-dependent effect of nanoparticles on permeation in this experimental model using fluorescent dextran molecules of different molecular weights. The system revealed permeation decreased as number of layers of cultured cells increased, or as molecule size increased. Furthermore, we showed changes in permeation depended on the source of the fibroblasts. Observations of this sort cannot be made in conventional monolayer culture systems. Thus our novel technique provides a promising in vitro means to investigate permeation of nanoparticles in fibrotic tissue, when both type and number of fibroblasts can be regulated.

Download full-text

Full-text

Available from: Michiya Matsusaki, Jan 13, 2015
1 Follower
 · 
236 Views
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: With recent approaches to tissue engineering, cells face various stresses from physical, chemical, and environmental stimuli. For example, coating of cell membranes with nanofilms using layer-by-layer (LbL) assembly requires many cycles of centrifugation causing physical (gravity) stress. Damage to cell membranes can cause leakage of cytosol molecules or sometimes cell death. Accordingly, we evaluated the effectiveness of LbL films prepared on cell membranes in protecting cells from physical stresses. After 2 steps of LbL assembly using Tris-HCl buffer solution without polymers or proteins (4 centrifugation cycles including washing), hepatocyte carcinoma (HepG2) cells showed extremely high cell death and viability was ca. 15%. Their viability ultimately decreased to 6% after 9 step LbL assembly (18 cycles of centrifugation), which is the typical number of steps involved in preparing LbL nanofilms. On the other hand, significantly higher viability (>85%) of HepG2 cells was obtained after 9 step LbL assembly employing fibronectin (FN)-gelatin (G) or type IV collagen (Col IV)-laminin (LN) solution combinations, which are typical components of extracellular matrix (ECM), to fabricate 10 nm thick LbL films. When LbL films of synthetic polymers created via electrostatic interactions were employed instead of ECM films described above, the viability of the HepG2 cells after the same 9 steps slightly decreased to 61%. The protective effects of LbL films were strongly dependent on their thickness and the critical thickness was over 5 nm. Surprisingly, high viability of over 85% was achieved even under extreme physical stress conditions (10,000 rpm). We evaluated the leakage of lactate dehydrogenase (LDH) during the LbL assembly processes to clarify the protective effect, and a reduction in LDH leakage was clearly observed when using FN-G nanofilms. Moreover, the LbL films do not inhibit cell growth during cell culture, suggesting that these coated cells can be useful for other experiments. LbL nanofilm coatings, especially ECM nanofilm coatings, will be important techniques for protecting cell membranes from physical stress during tissue engineering.
    Langmuir 10/2012; 29(24). DOI:10.1021/la303459v · 4.46 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Nanoparticles have received enormous attention as a promising tool to enhance target-specific drug delivery and diagnosis. Various in vitro and in vivo techniques are used to characterize a new system and predict its clinical efficacy. These techniques enable efficient comparison across nanoparticles and facilitate a product optimization process. On the other hand, we recognize their limitations as a prediction tool, which owe to inadequate applications and overly simplified test conditions. This article provides a critical review of in vitro and in vivo techniques currently used for evaluation of nanoparticles and introduces emerging techniques and models that may be used complementarily.
    Molecular Pharmaceutics 03/2013; 10(6). DOI:10.1021/mp300697h · 4.79 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Rapid and automatic development of three-dimensional (3D) human micro-tissue chips which integrate over 400 micro-arrays of simplified multilayered structures is carried out using inkjet printing technology. Comprehensive high-throughput assays of liver functions using the simplified 3D liver structures revealed highest functions of a sandwich structure of endothelial cells and hepatocytes. These 3D-human tissue chips may enable "total-human tissue models" for tailor-made drug screening.
    04/2013; 2(4). DOI:10.1002/adhm.201200299
Show more